Quality Control of a Strengthening Protocol in Subjects With Spinal Cord Injury
NCT ID: NCT03707704
Last Updated: 2020-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2018-10-10
2019-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
By default, the patients complete - depending on which training phase they are in - three to four strength training sessions per week. As part of the master's thesis, the development of maximum strength of patients with spinal cord injury (SCI) in primary rehabilitation will be studied. It is explicitly taken care of that the patients comply with the training requirements. Furthermore, factors which prevent a consistent buildup of strength - such as medical complications (pressure sores, pneumonia, urinary tract infections) - are systematically recorded.
The findings should provide information on the effect and qualitative transfer of the existing strength concept in everyday clinical practice. The strength training performed is accompanied by the master student and documented in a standardized manner.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Shoulder Health After Rehabilitation and Performance Training
NCT07245706
Performance Developement of Patients With Paraplegia During First Rehabilitation
NCT03405558
Strength Training With Eccentric Arm-cranking in Para-athletes
NCT05777941
Lokomat Versus Strength Training in Chronic Incomplete Spinal Cord Injury
NCT01087918
The Effects of Eccentric Compared to Standard Strength Training in Primary Spinal Cord Injury Rehabilitation
NCT06905470
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SCI patients in primary rehabilitation
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* SCI Level C1-C5 (ASIA Score C-D)
* SCI Lever C6-L5 (ASIA Score A-D)
* Traumatic and non-traumatic SCI
* Disease-related paraplegia, high-grade stenoses and central cord Syndromes
* Age \>= 18 years
* The maximum force is tested on three predefined training devices, two devices for the upper and a device for the lower extremity. The participants will only be included in the study if they are capable of succeeding in at least both exercises for the upper extremity
Exclusion Criteria
* Degenerative diseases such as multiple sclerosis and amyotrophic lateral sclerosis etc.
* Cognitive impairments
* Compliance of less than 2/3 of the training sessions
* ≥ 14 days without training
* more than 6 weeks between assessments
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Swiss Paraplegic Research, Nottwil
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Swiss Paraplegic Centre
Nottwil, Canton of Lucerne, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.